Predictors of fibrostenotic Crohnʼs disease
Authors:
- Florian RiederFRFlorian Rieder
- Ian C. LawranceILIan C. Lawrance
- Andre LeiteALAndre Leite
- Miquel SansMSMiquel Sans
- 1 September 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (9) , 2000-2007
Abstract
Intestinal fibrosis is a common and serious complication of Crohn's disease (CD) and as it can occur at any time during the disease course, it is crucial to identify patients at risk. The aim is not only to understand the pathophysiology of fibrogenesis but to be able to accurately inform subjects about their disease course, design future trials of potentially useful antifibrotic therapies, and, most important, identify those CD patients at risk, with the view to early, more aggressive medical therapy. This review summarizes the current status of our understanding and ability to predict fibrostenosing CD. The review encompasses three distinct areas: genetic variants, clinical phenotypes, and serologic markers in order to develop a conceptual framework for an understanding of fibrostenotic CD. It also aims to highlight where our knowledge is insufficient in order to identify areas that require future research.Keywords
This publication has 80 references indexed in Scilit:
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociNature Genetics, 2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialThe Lancet, 2008
- Genetic variation in DLG5 is associated with inflammatory bowel diseaseNature Genetics, 2004
- Functional variants of OCTN cation transporter genes are associated with Crohn diseaseNature Genetics, 2004
- Long-Term Evolution of Disease Behavior of Crohn's DiseaseInflammatory Bowel Diseases, 2002
- Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort studyThe Lancet, 2002
- Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the diseaseGut, 2001
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseNature, 2001
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseNature, 2001